CRP and neoplasm: The CRP-level correlated significantly with the tumour stage: 36.4 and 78.9% of all patients with a CRP ≤ and >5 mg/l suffered from muscle invasive disease (pT≥2) at the time diagnosis (p<0.001, Fisher’s exact test).